Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00718536
What this trial is testing

Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 15
Testing effectiveness (Phase 2)Study completedNCT01092104
What this trial is testing

A Proof of Concept Study to Evaluate the Antiviral Activity, Safety, and Pharmacokinetics of the CCR5 Antagonist TBR 652 in HIV 1-Infected, Antiretroviral Treatment-Experienced, CCR5 Antagonist-Naïve Patients

Who this might be right for
HIV-1 Infection
Tobira Therapeutics, Inc. 52
Not applicableUnknownNCT05531448
What this trial is testing

Two-way Texting (2wT) to Improve Antiretroviral (ART) Patient Retention in Malawi

Who this might be right for
Retention in Care
University of Washington 467
Testing effectiveness (Phase 2)Ended earlyNCT00823979
What this trial is testing

A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1

Who this might be right for
HIV-1
Pfizer 105
Early research (Phase 1)Study completedNCT00712530
What this trial is testing

Single DermaVir Immunization in HIV-1 Infected Patients on HAART

Who this might be right for
HIV Infection
Genetic Immunity 9
Not applicableStudy completedNCT02301507
What this trial is testing

Study of Cell Phone SMS to Improve Adherence to ART in HIV Positive Young Women

Who this might be right for
HIV Infection
The University of Texas Health Science Center, Houston 7
Not applicableStudy completedNCT01813292
What this trial is testing

Fluoride Metabolism, Bone Remodelling and Mineral Density in HIV Patients Treated With Tenofovir +/- Emtricitabine

Who this might be right for
HIV Seropositivity
Hopital Lariboisière 103
Early research (Phase 1)Study completedNCT00000865
What this trial is testing

The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 32
Large-scale testing (Phase 3)Study completedNCT01077765
What this trial is testing

Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy

Who this might be right for
HIV InfectionAntiretroviral Side EffectsLipodystrophy Syndrome Related to HIV Infection
Assistance Publique - Hôpitaux de Paris 100
Not applicableStudy completedNCT04357639
What this trial is testing

Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19 ( COVIP )

Who this might be right for
HIV Patients
Centre Hospitalier Intercommunal Creteil 1,040
Testing effectiveness (Phase 2)Study completedNCT03435146
What this trial is testing

Safety Tolerability DDI Short Course Treatment of LTBI Infection With High-dose Rifapentine and Isoniazid or Standard Isoniazid Preventive Therapy in HIV+ Patients (DOLPHIN & DOLPHIN TOO)

Who this might be right for
Respiratory Tract InfectionsHIV Infections
The Aurum Institute NPC 135
Not applicableStudy completedNCT01317277
What this trial is testing

Personalized Text Messages to Improve Antiretroviral Treatment (ART) Adherence in HIV+ Methamphetamine Users

Who this might be right for
HIVAIDS
University of California, San Diego 75
Not applicableStudy completedNCT00001119
What this trial is testing

Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 288
Not applicableUnknownNCT03878186
What this trial is testing

Efficacy Of A Cognitive Behavioral Therapy To Decrease Threat Appraisal In HIV Participants Initiating Antiretroviral

Who this might be right for
HIVThreat Appraisal
National Institute of Medical Sciences and Nutrition, Salvador Zubiran 50
Large-scale testing (Phase 3)Study completedNCT02263326
What this trial is testing

Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure

Who this might be right for
HIV Infection
Babafemi Taiwo 89
Not applicableStudy completedNCT01252537
What this trial is testing

Immunosuppression in HIV-infected Patients With Tuberculosis in Ethiopia

Who this might be right for
HIV InfectionTuberculosisImmunosuppression
Lund University 1,200
Not applicableStudy completedNCT05152953
What this trial is testing

Preparing for Pharmacy-based Delivery of Long-acting Injectable Antiretroviral Therapy (LAI-ART)

Who this might be right for
Hiv
University of California, San Francisco 63
Not applicableEnded earlyNCT00937729
What this trial is testing

Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules

Who this might be right for
HIV1 InfectionHIV Infections
University Hospital, Rouen 4
Early research (Phase 1)Ended earlyNCT05458102
What this trial is testing

Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus Levels

Who this might be right for
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Gilead Sciences 18
Not applicableStudy completedNCT03284645
What this trial is testing

Viral and Antiretroviral Dynamics in HIV-1 Mother-to-Child Transmission Fluids

Who this might be right for
Human Immunodeficiency Virus Infection
Obafemi Awolowo University 194
Next Page